Previously, we described a mAb (1-23) reacting with a novel cell surface antigen expressed on thymocytes at late CD4 -CD8 -[(double negative (DN)] to early CD4 ⍣ CD8 ⍣ [(double positive (DP)] differentiation stage. Since the expression of this molecule was restricted to immature thymocytes, we designated it as immature thymocyte antigen-1 (IMT-1). In this study, we have investigated the relevance of IMT-1 expression to thymocyte selection using TCR transgenic mice, scid mice or RAG-2 -/-mice. The IMT-1 ⍣ population in DP thymocytes was decreased in the thymuses of MHC class I-restricted or class II-restricted TCR transgenic mice with a positively selecting MHC background when compared with that of the mice with a non-selecting MHC background. IMT-1 ⍣ DP thymocytes were also decreased in TCR transgenic mice in which negative selection occurs. When DP thymocytes in H-Y TCR transgenic mice were stimulated with CD3ε mAb in vitro as well as in vivo, the expression of IMT-1 on DP thymocytes was decreased. Furthermore, the expression of IMT-1 on DN thymocytes from RAG-2 -/-mice was drastically reduced when CD3ε mAb was challenged in vivo. These results suggest that the expression of IMT-1 on DP or DN thymocytes is down-regulated by stimulation through TCR as well as pre-TCR. Taken together, these results show that IMT-1 is a unique surface marker which exquisitely separates pre-selected thymocytes from post-selected thymocytes.
Introduction
During the maturation of T cells in the thymus, the TCR complex plays important roles in determining the fate of T cell clones at two distinct differentiation stages. At the first stage, CD4 -CD8 -[double negative (DN)] immature thymocytes which underwent successful TCR β gene rearrangement produce the TCR β chain and express pre-TCR consisting of the pre-TCR α chain, TCR β chain and CD3 complex (1, 2) . Signaling through pre-TCR induces differentiation of DN thymocytes to CD4 ϩ CD8 ϩ [double positive (DP)] thymocytes and TCR α gene rearrangement (3) (4) (5) . The cells with successful TCR α gene rearrangement express TCR αβ and CD3 complex. At the second stage, cells expressing self-reactive TCR are negatively selected by the induction of apoptosis, whereas cells capable of recognizing foreign antigen in the context of self-MHC further differentiate into mature SP thymocytes. It has been shown that the fate of DP thymocytes is determined by the interaction of TCR and MHC-peptide complex (6, 7) , and that the avidity between TCR we describe that the IMT-1 ϩ population in DP thymocytes was reduced in TCR transgenic mice with a positively selecting MHC background as compared with the mice with nonselecting MHC background. We further show that the IMT-1 expression on the cell surface was reduced when DN thymocytes or DP thymocytes were stimulated by CD3ε mAb through pre-TCR or TCR. Our data suggest that IMT-1 is a unique T cell differentiation marker that can distinguish thymocytes before and after selection through TCR signaling.
Methods

Mice
H-Y TCR transgenic mice whose transgene encodes αβTCR specific to male (H-Y) antigen in the context of H-2D b MHC molecules (19, 21) were kindly provided by H.-S. Teh (University of British Columbia, Vancouver, Canada). OVA23-3 mice whose transgene encodes αβTCR recognizing an OVA peptide in the context of I-A d (20) were kindly provided by Dr S. Habu (Tokai University, Isehara, Japan). RAG-2 -/-mice that were backcrossed to C57BL/6 or BALB/c mice were kindly provided by the Central Institute for Experimental Animals (Kawasaki, Japan) with permission of Dr F. Alt (Harvard Medical School, Boston, MA). C.B.17 scid mice were purchased from Clea Japan (Tokyo, Japan). Antibodies 1-23 IMT-1 mAb (18) was purified by an anti-rat κ column from murine ascites and labeled with biotin. 145-2C11 CD3ε mAb was purified by a Protein A column from murine ascites. FITC-conjugated CD4 mAb (clone GK1.5) was prepared in our laboratory. FITC-conjugated CD8 mAb, Cy-Chromeconjugated CD8 mAb, phycoerythrin (PE)-conjugated CD4 mAb, FITC-conjugated CD69 mAb, biotinylated CD8 mAb and biotinylated rat IgM were purchased from PharMingen (San Diego, CA). Red670-conjugated streptavidin was purchased from Life Technologies (Gaithersburg, MD).
Cell staining and flow cytometric analysis
Cells were incubated with biotinylated 1-23 mAb or biotinylated rat IgM in staining buffer (PBS containing 2% FCS and 0.05% NaN 3 ) for 20 min on ice, and washed with the staining buffer 3 times. Then, the cells were reincubated with Red670-conjugated streptavidin together with FITC-conjugated CD8 and PE-conjugated CD4 mAb for 20 min on ice, and washed 3 times with the staining buffer. For the analysis of CD69 expression, cells were incubated with biotinylated CD8 mAb in the staining buffer for 20 min on ice. After washing, the cells were stained with Red670-conjugated streptavidin together with FITC-conjugated CD69 and PE-conjugated CD4 mAb for 20 min on ice. The stained cells were analyzed using a FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA).
Cell sorting and stimulation in vitro
Cells were stained with biotinylated 1-23 mAb and then with PE-conjugated streptavidin together with FITC-conjugated CD4 and Cy-Chrome-conjugated CD8 mAb as above. The stained cells were sorted using an Epics Elite (Coulter, Hialeah, FL). The sorted cells were cultured in RPMI 1640 containing 10% FCS and 5ϫ10 -5 M 2-mercaptoethanol in a 24-well plate (Becton Dickinson, Lincoln Park, NJ), the wells of which were coated with 1 µg/ml of 145-2C11 CD3ε mAb.
Immunoprecipitation
IMT-1 molecule was immunoprecipitated using a watersoluble cross-linker, 3,3Ј-dithiobis-sulfosuccinimidylpropionate (DTSSP; Pierce, Rockford, IL) according to the method described by Hamada and Tsuruo (27) . Briefly, cell surface proteins were labeled with 125 I using lactoperoxidase and glucose oxidase as described before (28) . Iodinated cells were incubated with biotinylated 1-23 mAb or biotinylated rat IgM for 20 min on ice and washed with PBS. Cell surface proteins and bound antibody were cross-linked by incubating the cells with 1 mM DTSSP in PBS at room temperature for 1 h. The reaction was stopped by washing cells with 100 mM Tris-HCl (pH 8.0) and 140 mM NaCl. Cells were then lysed in NP-40 lysis buffer containing 1% NP-40, 140 mM NaCl, 1 mM PMSF and 10 mM iodoacetamide at 4°C for 1 h. Cell lysates were precleared with Protein A-Sepharose, then incubated with streptavidin-coupled Dynabeads (Dynal, Oslo, Norway) for 1 h at 4°C. After washing the beads with NP-40 lysis buffer, precipitated antibodies and antigens were eluted and separated by boiling in SDS sample buffer in the presence of 5% 2-mercaptoethanol and analyzed by 7.5% SDS-PAGE. Where indicated, immunoprecipitates were treated with 1 U of N-glycosidase F at 37°C overnight before analysis by SDS-PAGE.
Results
Reduction of IMT-1 ϩ population in DP thymocytes in H-Y TCR transgenic mice under positively selecting MHC background
In the previous study, we showed that IMT-1 was specifically expressed on a part of DP thymocytes but not on CD4 ϩ or CD8 ϩ SP mature thymocytes (18) (Fig. 1) , posing a possibility that IMT-1 expression may be terminated during positive selection. In order to examine whether the TCR-mediated signals inducing the differentiation of DP thymocytes (positive selection) decrease the IMT-1 ϩ population in DP thymocytes, the expression of IMT-1 on subpopulations of thymocytes was compared between normal mice and H-Y TCR transgenic H-2 b female mice. In the transgenic H-2 b female mice, DP thymocytes expressing transgenic TCR are positively selected and differentiate into CD8 ϩ SP thymocytes by recognizing endogenous peptides in the context of H-2D b molecules (19) , hence the population of CD8 ϩ SP thymocytes increases (Fig.  1 ). In the transgenic mice, the IMT-1 ϩ population in DP thymocytes was found to be diminished when compared to that in non-transgenic littermates (Fig. 1) . We then examined the expression of IMT-1 on fetal thymocytes of H-Y TCR transgenic mice, in which selection events began to occur (Fig. 2) . Few DP thymocytes in the female transgenic fetuses expressed an activation marker, CD69, at day 17.5 of gestation. However, 10-12% of DP thymocytes became CD69 ϩ at day 18.5, indicating that a subpopulation of DP thymocytes in the female transgenic fetuses received signals for positive selection by day 18.5. At day 17.5 of gestation,~70-89% of DP thymocytes expressed IMT-1 in non-transgenic littermates, while 35-45% of DP thymocytes expressed IMT-1 in the female transgenic fetuses. At day 18.5, the percentage of IMT-1 ϩ DP thymocytes was drastically reduced (6-9%) in the female transgenic fetuses, while 44-55% of DP thymocytes expressed IMT-1 in non-transgenic littermates. These results suggest that the IMT-1 ϩ population in DP thymocytes is decreased under the condition in which DP thymocytes receive signals inducing positive selection.
In order to confirm that TCR-mediated signal induced the reduction of IMT-1 ϩ subpopulation in DP thymocytes, we generated H-Y TCR transgenic H-2 d/d or H-2 b/d scid mice by backcrossing H-Y TCR transgenic mice to C.B.17 scid mice and compared the IMT-1 expression on thymocytes. Thymocytes in H-Y TCR transgenic scid mice express the transgenic TCR but not endogenous TCR. As expected, DP thymocytes in the transgenic H-2 d/d scid mice could not differentiate into either CD4 ϩ or CD8 ϩ SP thymocytes, since the transgenic TCR could not receive signals in the absence of H-2D b molecules. On the contrary, DP thymocytes differentiated into CD8 ϩ SP thymocytes in the transgenic H-2 b/d female scid mice (Fig. 3) . In this situation, the IMT-1 ϩ population in DP thymocytes in the H-2 b/d scid mice (19-26%) was significantly less than that in the H-2 d/d scid mice (51-73%). The result confirms that a TCR-MHC interaction that induces positive selection of T cell precursors in thymus is responsible for the reduction of IMT-1 ϩ population in DP thymocytes.
Reduction of the IMT-1 ϩ population in DP thymocytes of MHC class II-restricted αβTCR transgenic mice The transgenic TCR of OVA23-3 mice recognizes an OVAderived peptide presented by I-A d molecules and positive selection occurs in the absence of the antigenic peptides in a H-2 d background (20) . In order to examine whether the expression of IMT-1 is also suppressed by a signal mediated by MHC class II-restricted TCR, we analyzed the IMT-1 expression on thymocytes of OVA23-3 TCR transgenic mice. As shown in Fig. 4 , the IMT-1 ϩ population of DP thymocytes in H-2 d OVA23-3 transgenic mice was clearly less than that of the H-2 b mice in which neither positive nor negative selection occurs. The result shows that the IMT-1 ϩ population in DP thymocytes in MHC class II-restricted TCR transgenic mice was also reduced under the condition inducing positive selection.
Reduction of IMT-1 ϩ DP thymocytes during negative selection
In adult H-Y TCR transgenic male mice, the number of DP thymocytes drastically decreases during negative selection (21) . In order to examine the effect of TCR signals that induce negative selection on the IMT-1 expression, we analyzed the cell number and expression of IMT-1 on fetal thymuses from H-Y TCR transgenic mice at days 17.5 and 18.5 of gestation (Fig. 5) . The number of DP thymocytes from the male transgenic fetuses corresponded to that in the non-transgenic littermates at day 17.5 of gestation. Between 30 and 50% of DP thymocytes in day 17.5 male transgenic fetuses expressed CD69, while 2-4% of DP thymocytes in the non-transgenic littermates expressed CD69, indicating that DP thymocytes in the male transgenic fetuses received signals for negative selection at day 17.5. After this, at day 18.5 of gestation, the number of DP thymocytes from the male transgenic fetuses was drastically reduced (Fig. 5) , showing that negative selection had occurred. When IMT-1 expression was investigated, shows staining profile using rat IgM (for negative control of 1-23 mAb) or without antibody (for negative control of CD69 mAb). At days 17.5 and 18.5 of gestation, cell recovery from two lobes of thymus was~1-2ϫ10 6 and 4-5ϫ10 6 respectively, and was not different significantly between non-transgenic and H-Y TCR transgenic female fetuses. Data are representative of two independent experiments with similar staining profiles of three to 10 fetuses. IMT-1 ϩ population in DP thymocytes from the female transgenic fetuses was less than that from non-transgenic littermates at day 17.5 of gestation (P Ͻ 0.05) and at day 18.5 of gestation (P Ͻ 0.003) (Mann-Whitney U-test).
70-89% of DP thymocytes expressed IMT-1 in non-transgenic littermates, while only 17-30% of DP thymocytes expressed IMT-1 in the male transgenic fetuses at day 17.5 of gestation. At day 18.5 of gestation, the percentage of IMT-1 ϩ DP thymocytes reduced to 1-7% in the male transgenic fetuses, while~44-55% of DP thymocytes remained to express IMT-1 in non-transgenic littermates. These results indicate that the IMT-1 ϩ population in DP thymocytes was reduced under the condition that induced negative selection.
Effect of TCR-mediated signal(s) on the expression of IMT-1 on DP thymocytes
In order to examine the effect of TCR-mediated signal on the expression of IMT-1 on DP thymocytes, CD3ε mAb was Fig. 1 ). Data are representative of similar staining profiles of four to five mice. The IMT-1 ϩ population in DP thymocytes from H-2 d mice was less than that from H-2 b mice (P Ͻ 0.03) (Mann-Whitney U-test). Fig. 2) . At days 17.5 and 18.5 of gestation, cell recovery from two lobes of thymus was~1-2ϫ10 6 and 4-5ϫ10 6 respectively, and was not different significantly between non-transgenic and H-Y TCR transgenic male fetuses. Data are representative of two independent experiments with similar staining profiles of three to 10 fetuses. The IMT-1 ϩ population in DP thymocytes from the transgenic male fetuses was less than that from non-transgenic littermates at day 17.5 of gestation (P Ͻ 0.03) and at day 18.5 of gestation (P Ͻ 0.003) (Mann-Whitney U-test).
i.p. injected into H-Y TCR transgenic female mice and the expression of IMT-1 and CD69 on DP thymocytes was examined. As shown in Fig. 6(A) , CD3ε mAb injection increased the CD69 ϩ population and reduced the IMT-1 ϩ population in DP thymocytes. Both the decrease in the IMT-1 ϩ population and the increase in the CD69 ϩ population in DP thymocytes was dependent on the dose of mAb (Fig. 6B) . Kinetics of the disappearance of IMT-1 ϩ DP thymocytes was in accordance with those of the appearance of CD69 ϩ DP thymocytes (Fig. 6C) . In Fig. 6(D) , the relationship between IMT-1 and CD69 expression on the activated thymocytes was analyzed in more detail by double staining. Before stimulation, most of thymocytes were IMT-1 ϩ CD69 -(73%), and minor populations were IMT-1 -CD69 ϩ (12%), IMT-1 ϩ CD69 ϩ (6%) and IMT-1 -CD69 -(9%). At 18 h after stimulation, the IMT-1 ϩ CD69 -population was decreased (18%) and the IMT-1 -CD69 ϩ population was increased (57%). The IMT-1 ϩ CD69 ϩ or IMT-1 -CD69 -population was not altered significantly (13 and 12% respectively). After 24 h, the IMT-1 ϩ CD69 -population disappeared and most of the thymocytes became IMT-1 - In order to directly examine the effect of TCR-mediated signal on IMT-1 expression on DP thymocytes, IMT-1 ϩ DP thymocytes were separated from H-Y TCR transgenic RAG-2 -/-H-2 d mice and cultured in the absence or the presence of CD3ε mAb in vitro. As shown in Fig. 6(E) , cell sizes were significantly increased by CD3ε mAb-stimulation, showing that the cells were activated. Without CD3ε mAb stimulation, 70-80% of DP thymocytes expressed IMT-1, while CD3ε mAb stimulation significantly reduced the expression of IMT-1 (20-30%) (Fig. 6E) . The numbers of live cells recovered from both cultures with or without CD3ε mAb were equivalent. Taken together, these results show that TCR-mediated signal downregulates the expression of IMT-1 on DP thymocytes.
Effect of CD3ε-mediated stimulation on the expression of IMT-1 on DN thymocytes in RAG-2 -/-mice It was reported that i.p. injection of CD3ε mAb induces activation and proliferation of DN thymocytes and differentiation into DP stage in RAG-2 -/-mice by the signals that mimic pre-TCR-mediated signals (22) . In order to examine the effect of pre-TCR-mediated signal(s) on the expression of IMT-1 in DN thymocytes, CD3ε mAb was i.p. injected into RAG-2 -/-mice and the expression of IMT-1 was examined (Fig. 7) . When PBS was injected, 80-85% of RAG-2 -/-thymocytes expressed IMT-1 and 5-6% of them expressed CD69 on the cell surface. When CD3ε mAb was injected, the total number of thymocytes was remarkably increased (~8-to 20-fold), accompanied with the increase in the expression of CD69 (75-80%). On the contrary, the IMT-1 ϩ population was drastically decreased (2-10%) with the CD3ε mAb stimulation. The results indicate that the expression of IMT-1 was also suppressed during the activation and differentiation of DN thymocytes by the signal(s) that mimic pre-TCR signals.
Identification and characterization of the IMT-1 molecule
In the previous study, we showed that the epitope of 1-23 IMT-1 mAb exists on a trypsin-and collagenase-sensitive and non-GPI-linked protein (18) . However, further characterization of IMT-1 by either standard immunoprecipitation or immunoblotting was hampered, probably due to the low affinity of the IMT-1 mAb. In the present study, we tried to precipitate the IMT-1 molecule by using a water-soluble cross-linker, DTSSP. As shown in Fig. 8, 1 -23 mAb specifically precipitated a 150 kDa molecule from the IMT-1-expressing LSB11-14 thymic lymphoma cell line and normal murine thymocytes, but not from IMT-1 non-expressing LSB11-1 cells. When immunoprecipitates were treated with N-glycosidase F, the antigen migrated to 140 kDa. These results indicate that IMT-1 is an N-glycosylated protein with a mol. wt of 150 kDa.
Discussion
In this study, we have demonstrated that IMT-1, an N-glycosylated protein with a mol. wt of 150 kDa, is expressed on the cell surface of DN as well as DP immature thymocytes and that it disappears from the cell surface by the signals through pre-TCR or αβTCR. Since IMT-1 had been shown to be expressed on a subpopulation of DP immature thymocytes but not on SP mature thymocytes (18), we postulated that the IMT-1 ϩ population in DP thymocytes may be affected by the signals through TCR that induce positive and/or negative selection of thymocytes. The present data supported this presumption; in class I-specific or class II-specific TCR transgenic mice with a positively selecting MHC background, but not in the mice with a non-selecting MHC background, the IMT-1 ϩ population in DP thymocytes was diminished (Figs 1-4) . It was also demonstrated that IMT-1 ϩ population was reduced under the condition in which negative selection occurred (Fig. 5) . These results indicated that the expression of IMT-1 is down-regulated by the signals through TCR. An alternative interpretation of these results may be that the decrease in IMT-1 ϩ DP thymocytes in TCR transgenic mice is a consequence of an equilibrium of the selective input of IMT-1 -cells and the selective output or deletion of IMT-1 ϩ cells in thymus. In order to rule out the latter possibility, we isolated IMT-1 ϩ DP thymocytes of H-Y TCR transgenic mice and stimulated them with CD3ε mAb in vitro (Fig. 6) . We found that stimulation with CD3ε mAb suppressed the expression of IMT-1 on the DP thymocytes (from 66 to 16%) without any effect on cell growth. The results strongly suggest that IMT-1 expression is down-regulated by the signals through TCR-CD3 complexes on DP thymocytes.
Recent studies show that DN thymocytes with successful TCR β gene rearrangements express pre-TCR, consisting of pre-TCRα, TCRβ and CD3 complex (1, 2) . It was reported that although CD3ε was hardly detectable on the cell surface of DN thymocytes in RAG-1 -/-or RAG-2 -/-mice, in vivo stimulation of DN thymocytes in these mice with CD3ε mAb caused the proliferation and differentiation of DN thymocytes into DP thymocytes (22, 23) . From these observations, it was assumed that the activation of DN thymocytes with CD3ε mAb can substitute for the activation signaling through pre-TCR expressed on DN thymocytes. In this study, we showed that the in vivo activation of DN thymocytes in RAG-2 -/-mice with CD3ε mAb induced the increase in the cell number as well as the cell surface expression of CD69, while the expression of IMT-1 was drastically reduced by the challenge of CD3ε mAb (Fig. 7) . The result indicates that the expression of IMT-1 was down-regulated after the activation of DN thymocytes through CD3ε. Alternatively, the IMT-1 -population in DN thymocytes preferentially increased by the stimulation through CD3ε. We believe the latter possibility is less likely because in some experiments CD3ε mAb injection into RAG-2 -/-mice induced the complete loss of IMT-1 expression on the DN population with little effect on cell expansion (see legend for Fig. 7 ). These observations favor the conclusion that the disappearance of the IMT-1 ϩ population may be due to the down-regulation of IMT-1 expression induced by CD3ε mAbstimulation, but not due to the cell expansion of IMT-1 -cells.
When RAG-2 -/-thymocytes were analyzed at 1 week after CD3ε mAb administration, we observed that RAG-2 -/-thymocytes differentiated into DP thymocytes and a part of them re-expressed IMT-1 on the cell surface (unpublished data). Considering this, it is supposed that during the differentiation of thymocytes, IMT-1 on DN thymocytes is down-regulated by the signals through pre-TCR, then it is re-expressed during the differentiation into DP thymocytes and finally IMT-1 on DP thymocytes is re-down-regulated when the cells receive signals through αβTCR.
We found that the IMT-1 ϩ population in DN thymocytes of TCR transgenic mice was significantly reduced compared to non-transgenic littermates (Fig. 1) . This reduction of the IMT-1 ϩ population in DN thymocytes was observed both in the transgenic mice with selective MHC background and in the mice with a non-selective MHC background (data not shown), suggesting that the interaction of αβTCR on DN thymocytes and MHC/peptide complex on thymic epithelial cells is not responsible for the reduction of IMT-1 expression. How did these DN thymocytes receive the activation signals? In this regard, Buer et al. have recently demonstrated that transgenic αβTCR can partially substitute for pre-TCR in pTα -/-mice to induce the differentiation of DN thymocytes to DP thymocytes (24) . Thus, it is likely that the reduction of IMT-1 expression on the DN population of the H-Y TCR transgenic mice is a consequence of signal transduction through the transgenic αβTCR expressed on the DN population in a MHC-independent manner.
Akashi and Weissman showed that TCR low , c-kit high thymocytes with intermediate levels of CD4 and CD8 contained progenitors that had not received TCR-mediated positive selection (25) . In this regard, the IMT-1 ϩ thymocyte population also consisted of DP thymocytes with intermediate levels of CD4 and CD8, as well as DN thymocytes (data not shown). In thymus, c-kit was shown to be primarily expressed on subpopulations of CD3 -DN thymocytes including the least mature CD44 ϩ CD25 -population (26) . Since IMT-1 was not expressed on CD44 ϩ CD25 -DN thymocytes (18), it is conceivable that IMT-1 may be more specifically expressed on preselected thymocytes.
In summary, we showed evidence that IMT-1 is expressed on DN as well as DP thymocytes that do not receive the activation signals through pre-TCR or αβTCR. We consider that IMT-1 may be a unique and useful thymocyte differentiation marker that can discriminate pre-selected immature thymocytes and post-selected thymocytes. to use RAG-2 -/-mice. This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports of Japan. 
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